Evaluating the 21-Gene Assay Recurrence Score® as a Predictor of Clinical Response to 24 Weeks of Neoadjuvant Exemestane in Estrogen Receptor-Positive Breast Cancer

International Journal of Clinical Oncology - Japan
doi 10.1007/s10147-013-0614-x
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Distribution Patterns of 21-Gene Recurrence Score in 980 Chinese Estrogen Receptor-Positive, HER2-negative Early Breast Cancer Patients

Oncotarget
Oncology
2017English

Association Between the 21-Gene Recurrence Score and Isolated Local-Regional Recurrence in Hormone Receptor-Positive Breast Cancer

International Journal of Radiation Oncology Biology Physics
OncologyRadiologyCancer ResearchRadiationNuclear MedicineImaging
2016English

Neoadjuvant Endocrine Therapy for Estrogen Receptor–Positive Breast Cancer

JAMA Oncology
Cancer ResearchOncology
2016English

Validation of the 21-Gene Test as a Predictor of Clinical Response to Neoadjuvant Hormonal Therapy for ER+, HER2-negative Breast Cancer: The TransNEOS Study

Breast Cancer Research and Treatment
Cancer ResearchOncology
2018English

Cost-Effectiveness Analysis of Recurrence Score-Guided Treatment Using a 21-Gene Assay in Early Breast Cancer

Oncologist
Cancer ResearchMedicineOncology
2010English

TOP2A RNA Expression and Recurrence in Estrogen Receptor-Positive Breast Cancer

Breast Cancer Research and Treatment
Cancer ResearchOncology
2012English

Treatment Decisions in Estrogen Receptor-Positive Early Breast Cancer Patients With Intermediate Oncotype DX Recurrence Score Results

SpringerPlus
Multidisciplinary
2014English

Lymph Node Involvement: Positive About the Role of the Recurrence Score in Estrogen-Driven Breast Cancer?

Cancer
Cancer ResearchOncology
2018English

The Impact of Oncotype DX® Recurrence Score of Paraffin-Embedded Core Biopsy Tissues in Predicting Response to Neoadjuvant Chemotherapy in Women With Breast Cancer

Breast Disease
MedicineCancer ResearchOncology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy